Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
出版年份 2020 全文链接
标题
Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
作者
关键词
-
出版物
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-06
DOI
10.1007/s12016-020-08791-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Designing a new dimerized anti human TNF‐α aptamer with blocking activity
- (2020) Kazem Mashayekhi et al. BIOTECHNOLOGY PROGRESS
- V617F‐independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease
- (2019) Hamid Asadzadeh‐Aghdaei et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals
- (2018) Anna J. Boland et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Are toll-like receptors potential drug targets for atherosclerosis? Evidence from genetic studies to date
- (2018) Christopher P. Nelson et al. IMMUNOGENETICS
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Overview of the IL-1 family in innate inflammation and acquired immunity
- (2017) Charles A. Dinarello IMMUNOLOGICAL REVIEWS
- Role of NLRP3 Inflammasomes in Atherosclerosis
- (2017) Tadayoshi Karasawa et al. Journal of Atherosclerosis and Thrombosis
- Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment
- (2017) Alkistis Kapelouzou et al. JOURNAL OF VASCULAR RESEARCH
- Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes
- (2017) Zhen-Huan Lv et al. Oncotarget
- NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
- (2017) Beibei Luo et al. Frontiers in Physiology
- Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
- (2016) Piotr Chruściel et al. ATHEROSCLEROSIS
- Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes
- (2016) Fanqi Kong et al. BIOMEDICINE & PHARMACOTHERAPY
- Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
- (2016) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The role of the inflammasome in patients with autoinflammatory diseases
- (2016) Hal M. Hoffman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- The impact of statin therapy on plasma levels of von Willebrand factor antigen
- (2016) Amirhossein Sahebkar et al. THROMBOSIS AND HAEMOSTASIS
- NOD-Like Receptors in Infection, Immunity, and Diseases
- (2016) Young Keun Kim et al. YONSEI MEDICAL JOURNAL
- NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
- (2016) Geena Paramel Varghese et al. Journal of the American Heart Association
- Oxidized Low‐Density Lipoprotein (OxLDL)–Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let‐7c Is Integral to the Effect
- (2016) Johan Frostegård et al. Journal of the American Heart Association
- Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
- (2015) Justine M. Abais et al. ANTIOXIDANTS & REDOX SIGNALING
- Platelet P2Y12Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human ModelSignificance
- (2015) Mark R. Thomas et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials
- (2015) Amirhossein Sahebkar et al. ATHEROSCLEROSIS
- Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin–angiotensin system blockade
- (2015) Mamoru Satoh et al. CLINICAL SCIENCE
- NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins
- (2015) Afrasyab Altaf et al. CORONARY ARTERY DISEASE
- Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development inLdlr−/−mice
- (2015) Tim Hendrikx et al. FEBS Journal
- Simvastatin protects the heart against ischemia reperfusion injury via inhibiting HMGB1 expression through PI3K/Akt signal pathways
- (2015) Qian-Feng Han et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation
- (2015) KUANG PENG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipids, blood pressure and kidney update 2014
- (2015) Maciej Banach et al. PHARMACOLOGICAL RESEARCH
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Is immunity a mechanism contributing to statin-induced diabetes?
- (2015) Brandyn D Henriksbo et al. Adipocyte
- Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size
- (2014) Manjyot K. Nanhwan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
- (2014) Xiao Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis
- (2014) Z. Ding et al. CARDIOVASCULAR RESEARCH
- Statin-Induced Insulin Resistance Through Inflammasome Activation: Sailing Between Scylla and Charybdis
- (2014) Patricia Mitchell et al. DIABETES
- Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
- (2014) Brandyn D. Henriksbo et al. DIABETES
- 3-Hydroxyl-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor (Statin)-induced 28-kDa Interleukin-1β Interferes with Mature IL-1β Signaling
- (2014) Facundo Davaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
- (2014) Fei Zheng et al. MEDIATORS OF INFLAMMATION
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
- (2013) Amirhossein Sahebkar et al. CARDIOVASCULAR DRUGS AND THERAPY
- NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin
- (2013) Mamoru Satoh et al. CLINICAL SCIENCE
- The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity
- (2013) Gudrun Ulrich-Merzenich et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- LOX-1, OxLDL, and Atherosclerosis
- (2013) Angela Pirillo et al. MEDIATORS OF INFLAMMATION
- Inhibition of nuclear factor-erythroid 2–related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence
- (2013) Daniela Volonte et al. MOLECULAR BIOLOGY OF THE CELL
- Effect of atorvastatin on expression of TLR4 and NF-κB p65 in atherosclerotic rabbits
- (2013) Ding-Zhu Shen et al. Asian Pacific Journal of Tropical Medicine
- Statins and Pulmonary Fibrosis
- (2012) Jin-Fu Xu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide – Induced cytokine production in monocytes of hypercholesterolemic patients
- (2012) Elisavet Moutzouri et al. ATHEROSCLEROSIS
- Effects of HMG-CoA Reductase Inhibitor on Experimental Autoimmune Myocarditis
- (2012) Xiaoman Liu et al. CARDIOVASCULAR DRUGS AND THERAPY
- Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells
- (2012) Shuan Suo Yang et al. CELLULAR IMMUNOLOGY
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
- (2012) M. Rajesh et al. DIABETES
- Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF
- (2012) Sawsan A. Zaitone et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats
- (2012) W.B. Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation
- (2012) Y.-H. Liao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Statins as potential therapeutic drug for asthma?
- (2012) Cheng Yuan et al. RESPIRATORY RESEARCH
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice
- (2011) Vinay Bhaskar et al. ATHEROSCLEROSIS
- Rosuvastatin improves endothelial function indb/dbmice: role of angiotensin II type 1 receptors and oxidative stress
- (2011) XY Tian et al. BRITISH JOURNAL OF PHARMACOLOGY
- TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
- (2011) Yun Ti et al. DIABETES
- The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients
- (2011) Murat Koksal et al. European Journal of Internal Medicine
- Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats
- (2011) Amany A. Abdin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: Effect of statins on let-7i and Toll-like receptor 4 signal
- (2011) Mamoru Satoh et al. IMMUNOBIOLOGY
- The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases
- (2011) Qing Lin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction
- (2011) Gemma Vilahur et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Simvastatin Therapy Reduces Prooxidant-Antioxidant Balance: Results of a Placebo-Controlled Cross-Over Trial
- (2011) Seyyed M. R. Parizadeh et al. LIPIDS
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Anti-inflammatory therapeutics for the treatment of atherosclerosis
- (2011) Israel F. Charo et al. NATURE REVIEWS DRUG DISCOVERY
- Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins
- (2011) Athanasios Katsargyris et al. Vascular
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
- (2011) P Menu et al. Cell Death & Disease
- Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
- (2010) Adrià Arboix et al. BMC Neurology
- The Alternative Pathway Is Critical for Pathogenic Complement Activation in Endotoxin- and Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
- (2010) Talat H. Malik et al. CIRCULATION
- Expression ofmiR-146a/bis associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin–angiotensin system blockade and statins onmiRNA-146a/band Toll-like receptor 4 levels
- (2010) Yuji Takahashi et al. CLINICAL SCIENCE
- Atorvastatin affects TLR4 clustering via lipid raft modulation
- (2010) Praveen Chansrichavala et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
- (2010) George S. Abela Journal of Clinical Lipidology
- The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4
- (2010) Jun Yang et al. MOLECULAR BIOLOGY REPORTS
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Monocytes in atherosclerosis: subsets and functions
- (2010) Kevin J. Woollard et al. Nature Reviews Cardiology
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
- Effect of Cholesterol Crystals on Plaques and Intima in Arteries of Patients With Acute Coronary and Cerebrovascular Syndromes
- (2009) George S. Abela et al. AMERICAN JOURNAL OF CARDIOLOGY
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
- (2009) Seth L. Masters et al. Annual Review of Immunology
- Immune and Inflammatory Mechanisms of Atherosclerosis
- (2009) Elena Galkina et al. Annual Review of Immunology
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Inflammatory arthritis in caspase 1 geneâdeficient mice: Contribution of proteinase 3 to caspase 1âindependent production of bioactive interleukin-1β
- (2009) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- Toll like receptor 4 in atherosclerosis and plaque destabilization
- (2009) Wijnand K. den Dekker et al. ATHEROSCLEROSIS
- Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake
- (2009) Soo-Ho Choi et al. CIRCULATION RESEARCH
- Innate immune signals in atherosclerosis
- (2009) Anna M. Lundberg et al. CLINICAL IMMUNOLOGY
- Effect of Targeting Mitogen-Activated Protein Kinase on Cardiac Remodeling in Rats
- (2009) Azza Baraka et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Therapeutic potential of statins in Alzheimer's disease
- (2009) Nagaendran Kandiah et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways
- (2009) Emin Ozbek et al. RENAL FAILURE
- The NLRP3 inflammasome: A sensor of immune danger signals
- (2009) Suzanne L. Cassel et al. SEMINARS IN IMMUNOLOGY
- Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke
- (2008) John Protopsaltis et al. ATHEROSCLEROSIS
- Statin synergizes with LPS to induce IL-1β release by THP-1 cells through activation of caspase-1
- (2008) Loes M. Kuijk et al. MOLECULAR IMMUNOLOGY
- Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression
- (2008) Conrad P. Hodgkinson et al. Pharmacogenetics and Genomics
- CX 3 CR1 Deficiency Impairs Dendritic Cell Accumulation in Arterial Intima and Reduces Atherosclerotic Burden
- (2007) Peng Liu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity
- (2007) Jussi A. Hernesniemi et al. ATHEROSCLEROSIS
- Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve
- (2007) D Versteeg et al. HEART
- Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure
- (2007) Gábor Földes et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search